| ARESAres Management Corp |
US$ 5,6 bi |
9,4% |
2025 |
| ZAREAres Real Estate Income Trust Inc. |
US$ 498,8 mi |
-13,6% |
2025 |
| ARBKArgo Blockchain Plc |
US$ 47 mi |
-117,2% |
2024 |
| ARHSArhaus, Inc. |
US$ 1,4 bi |
4,9% |
2025 |
| ARISAris Mining Corp |
US$ 927,7 mi |
8,4% |
2025 |
| ANETArista Networks, Inc. |
US$ 9 bi |
39,0% |
2025 |
| ARKBArk 21Shares Bitcoin ETF |
n/d |
n/d |
2025 |
| ARLOArlo Technologies, Inc. |
US$ 529,3 mi |
2,8% |
2025 |
| XRPNArmada Acquisition Corp. II |
n/d |
n/d |
2025 |
| AACIArmada Acquisition Corp. III |
n/d |
n/d |
n/d |
| ARMPArmata Pharmaceuticals, Inc. |
n/d |
n/d |
2025 |
| BTOCArmlogi Holding Corp. |
US$ 190,4 mi |
-8,1% |
2025 |
| ARRArmour Residential REIT, Inc. |
n/d |
n/d |
2025 |
| ARQArq, Inc. |
US$ 120,3 mi |
-43,7% |
2025 |
| ARQQArqit Quantum Inc. |
US$ 293 mil |
-18.628,3% |
2024 |
| ARRYArray Technologies, Inc. |
US$ 1,3 bi |
-4,1% |
2025 |
| AVBPArriVent BioPharma, Inc. |
n/d |
n/d |
2025 |
| ARAIArrive AI Inc. |
US$ 113,3 mil |
-11.325,7% |
2025 |
| BANXArrowMark Financial Corp. |
n/d |
n/d |
n/d |
| ARTCArt Technology Acquisition Corp. |
n/d |
n/d |
n/d |
| AIPArteris, Inc. |
US$ 70,6 mi |
-49,2% |
2025 |
| AJGArthur J. Gallagher & Co. |
US$ 13,9 bi |
10,7% |
2025 |
| AITXArtificial Intelligence Technology Solutions Inc. |
US$ 7,7 mi |
-187,3% |
2026 |
| ARRTArtisan Consumer Goods, Inc. |
n/d |
n/d |
2025 |
| APAMArtisan Partners Asset Management Inc. |
US$ 1,2 bi |
24,3% |
2025 |
| AACBArtius II Acquisition Inc. |
n/d |
n/d |
2025 |
| ARTVArtiva Biotherapeutics, Inc. |
US$ 0 |
n/d |
2025 |
| ARXSArxis, Inc. |
n/d |
n/d |
n/d |
| ASANAsana, Inc. |
US$ 790,8 mi |
-23,9% |
2026 |
| AAWHAscend Wellness Holdings, Inc. |
US$ 500,6 mi |
-23,6% |
2025 |
| ASNDAscendis Pharma A/S |
€ 720,1 mi |
-31,7% |
2025 |
| ASTIAscent Solar Technologies, Inc. |
US$ 76,8 mil |
-10.202,5% |
2025 |
| SORAAsiaStrategy |
US$ 11 mi |
111,9% |
2025 |
| AWHLAspira Women's Health Inc. |
US$ 9,2 mi |
-138,7% |
2025 |
| ASBPAspire Biopharma Holdings, Inc. |
US$ 6,2 mil |
-394.725,1% |
2025 |
| ACGPAssociated Capital Group, Inc. |
US$ 13,2 mi |
336,5% |
2024 |
| ALABAstera Labs, Inc. |
US$ 852,5 mi |
25,7% |
2025 |
| ASTHAstrana Health, Inc. |
US$ 3,2 bi |
0,7% |
2025 |
| ALOTAstroNova, Inc. |
US$ 150,5 mi |
-1,6% |
2026 |
| ACRLAtacama Resources International, Inc. |
US$ 0 |
n/d |
2016 |
| ATAIAtaiBeckley Inc. |
US$ 4,1 mi |
-16.142,0% |
2025 |
| ATRAAtara Biotherapeutics, Inc. |
US$ 120,8 mi |
27,1% |
2025 |
| AVIRAtea Pharmaceuticals, Inc. |
n/d |
n/d |
2025 |
| ASICAtegrity Specialty Insurance Co Holdings |
US$ 424,3 mi |
17,4% |
2025 |
| ATERAterian, Inc. |
US$ 69 mi |
-27,5% |
2025 |
| ABITAthena Bitcoin Global |
US$ 234,6 mi |
-2,6% |
2025 |
| ATHSAthene Holding Ltd. |
US$ 25,7 bi |
10,6% |
2025 |
| ATKRAtkore Inc. |
US$ 2,9 bi |
-0,5% |
2025 |
| BATRAAtlanta Braves Holdings, Inc. |
US$ 732,5 mi |
-3,2% |
2025 |
| AUBAtlantic Union Bankshares Corp |
n/d |
n/d |
2025 |